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Background
Our aim is to identify causal variants for the IL1RL1
gene previously associated with asthma and related phe-
notypes as well as perform functional assays to uncover
the mechanism underlying its involvement in the disease
pathogenesis. IL1RL1 has been shown to be sufficient to
induce experimental allergic airway inflammation using
transgenic and knockdown mouse models. Its expression
has been shown to increase in murine and human asth-
matic lungs; the ligand for IL1RL1 is Interleukin-33
(IL33). The signaling cascade resulting from the binding
of TSLP and IL33 is crucial in eosinophilic inflammation
characteristic of asthma. The IL1RL1 gene lies in chro-
mosome 2 in the midst of a cytokine gene cluster with
IL1R1, IL1RL2, IL18R1 and IL18RAP:a l le n c o d i n gf o r
proteins involved in the immune response characteristic
of asthma. The region is in relatively high linkage dise-
quilibrium, thus an excellent candidate for narrowing
down the asthma association signal to one or more cau-
sal SNPs.
Methods
Firstly, a putative causal SNP is identified based on pre-
vious association data, or linkage disequilibrium with
associated SNPs, conservation scores and putative bind-
ing of regulatory proteins.
DNA samples from asthmatics and controls are then
genotyped for the candidate SNP using Taqman tech-
nology in order to relate genotypes to potential altera-
tion of gene expression.
Gene expression assays will be performed to compare
levels of expression between the different genotypes as
well as between the two SNP alleles. These real time-
polymerase chain reaction (RT-PCR) experiments will
be conducted for both IL1RL1 isoforms in order to also
assess their differential expression depending on our
candidate SNP genotype. If changes in expression are
observed, we will perform electrophoretic mobility shift
assays in order to test if the differential expression is
due to the differential binding of a regulatory protein
depending on the SNP allele. In order to further con-
firm that the SNP site is in an important region for
gene expression regulation we will perform formalde-
hyde-assisted isolation of regulatory elements (FAIRE); a
method which discriminates between DNA sequences
depending on the presence or lack of nucleosome struc-
tures. The absence of nucleosome indicates that the
region is active and accessible to regulatory elements
and thus important for gene regulation.
Findings
We have selected the IL1RL1 SNP rs1420101 based on
t h ef a c tt h a ti tw a st h em o s ts i g n i f i c a n ts i g n a li nag e n -
ome-wide study about eosinophil counts and the same
SNP associated with asthma in ten populations in the
same study. During the optimization phase of our gene
expression assays, we confirmed differential expression
of the IL1RL1 isoforms in RNA samples from blood of
asthmatic children as well as controls. The next step is
to relate that differential expression to the SNP geno-
type as well as continue with RT-PCR to compare
allele-specific expression.
Conclusions and relevance
The overall objective of this research is to enhance our
understanding of the pathogenesis of asthma by narrow-
ing down genetic association signals to specific causal
variants. Not only will this strengthen the evidence for
IL1RL1 being an asthma gene but it will also help
untangle the association signal from this region. Reach-
ing a greater understanding of the molecular
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novel therapies targeting the source of inflammation
rather than life-long therapies aimed at dampening
inflammation and easing symptoms.
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